| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 12.890 | - | 66.897 | - | 42.614 | 50.316 | - | - | - |
| Total Income - EUR | - | 12.890 | - | 73.774 | - | 43.147 | 50.317 | - | - | - |
| Total Expenses - EUR | - | 13.710 | - | 73.010 | - | 46.383 | 32.828 | - | - | - |
| Gross Profit/Loss - EUR | - | -821 | - | 765 | - | -3.236 | 17.489 | - | - | - |
| Net Profit/Loss - EUR | - | -1.058 | - | 27 | - | -3.662 | 16.986 | - | - | - |
| Employees | - | 2 | - | 3 | - | 2 | 1 | - | - | - |
Check the financial reports for the company - Allepharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 87 | - | 0 | - | 0 | 0 | - | - | - |
| Current Assets | - | 8.932 | - | 114.500 | - | 129.664 | 152.929 | - | - | - |
| Inventories | - | 5.242 | - | 17.086 | - | 1.500 | 1.256 | - | - | - |
| Receivables | - | 2.704 | - | 84.935 | - | 105.658 | 131.711 | - | - | - |
| Cash | - | 986 | - | 12.479 | - | 22.505 | 19.962 | - | - | - |
| Shareholders Funds | - | -1.257 | - | -7.980 | - | -21.853 | -4.382 | - | - | - |
| Social Capital | - | 45 | - | 43 | - | 41 | 40 | - | - | - |
| Debts | - | 10.275 | - | 122.480 | - | 151.516 | 157.312 | - | - | - |
| Income in Advance | - | 0 | - | 0 | - | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Allepharm Srl